This technology can be incorporated into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential. Nutriband’s lead product under ...

The AVERSA™ transdermal abuse deterrent technology is protected by a broad international intellectual property portfolio with patents already issued in 46 countries including the United States, Europe ...

This technology can be incorporated into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential. Nutriband’s lead product under ...

The AVERSA™ transdermal abuse deterrent technology is protected by a broad international intellectual property portfolio with patents already issued in 46 countries including the United States ...

The expected issuance of this patent further expands Nutriband’s intellectual property protection in the United States for its portfolio of abuse deterrent transdermal products based on its ...

Optical fibers are fundamental components in modern science and technology due to their inherent advantages, providing an ...

Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function More than 800 million people have ...

These patches are more formally referred to as ‘transdermal patches’ or ‘skin patches’ as they use a Transdermal Drug Delivery System (TDDS). TDDS, in simple words, is a system that ...

The growth of 5G technology is also a significant factor driving the optical transceiver market. As 5G networks are deployed worldwide, the demand for high-capacity and low-latency data ...

Used with widely available positron emission tomography (PET) and optical imaging technology, these novel targeting agents are able to bind specifically to cell surface targets. The company is backed ...